Screening for colorectal cancer

Annals of Internal Medicine

Volumn 160, Issue 9, 2014, Pages

  Weinberg, David S ^a   Schoen, Robert E ^a   Cotton, Deborah ^a   Rao, Jaya K ^a   Taichman, Darren ^a   Williams, Sankey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CANCER PREVENTION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; FAMILY HISTORY; FECAL IMMUNOCHEMICAL TESTING; FECAL OCCULT BLOOD TESTING; FLEXIBLE SIGMOIDOSCOPY; HUMAN; IMMUNOCHEMISTRY; MEDICAL SOCIETY; OCCULT BLOOD TEST; PATIENT INFORMATION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIGMOIDOSCOPY; UNITED STATES; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH BEHAVIOR; MASS SCREENING; METHODOLOGY; OCCULT BLOOD; PATIENT EDUCATION; PRACTICE GUIDELINE; RISK FACTOR;

AGE FACTORS; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; HEALTH BEHAVIOR; HUMANS; MASS SCREENING; OCCULT BLOOD; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84902987885     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-160-9-201405060-01005     Document Type: Review

References (68)

1. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2012. [PMID: 22261986]
2. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714-36. [PMID: 21454908]
3. Steele CB, Rim SH, Joseph DA, et al; Centers for Disease Control and Prevention (CDC). Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill Summ. 2013;62 Suppl 3:53-60. [PMID: 24264490]
4. Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863-72. [PMID: 17079760]
5. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-56. [PMID: 11231939]
6. Schoen RE, Pinsky PF, Weissfeld JL, et al; PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-57. [PMID: 22612596]
7. Taylor DP, Burt RW, Williams MS, et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010;138:877-85. [PMID: 19932107]
8. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992-3003. [PMID: 11693338]
9. Qaseem A, Denberg TD, Hopkins RH Jr, et al; Clinical Guidelines Committee of the American College of Physicians. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378-86. [PMID: 22393133]
10. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095-105. [PMID: 24047059]
11. Schoen RE, Pinsky PF, Weissfeld JL, et al. Utilization of surveillance colonoscopy in community practice. Gastroenterology. 2010;138:73-81. [PMID: 19818779]
12. Losi L, Di Gregorio C, Pedroni M, et al. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am J Gastroenterol. 2005;100:2280-7. [PMID: 16181381]
13. Coups EJ, Manne SL, Meropol NJ, et al. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev. 2007;16:510-6. [PMID: 17372246]
14. Rothwell PM. Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits. Recent Results Cancer Res. 2013;191:121-42. [PMID: 22893203]
15. U.S. Preventive Services Task Force. Routine aspirin or nons-teroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;146:361-4. [PMID: 17339621]
16. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-7. [PMID: 11096167]
17. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375:1624-33. [PMID: 20430429]
18. Leung K, Pinsky P, Laiyemo AO, et al. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc. 2010;71:111-7. [PMID: 19647250]
19. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306:1352-8. [PMID: 21954479]
20. Lieberman DA, Rex DK, Winawer SJ, et al; United States MultiSociety Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844-57. [PMID: 22763141]
21. Singh H, Nugent Z, Demers AA, et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010;105:2588-96. [PMID: 20877348]
22. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795-803. [PMID: 20463339]
23. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298-306.
24. Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50:29-32. [PMID: 11772963]
25. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-7. [PMID: 8942775]
26. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71. [PMID: 8474513]
27. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. [PMID: 10070942]
28. Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106-14. [PMID: 24047060]
29. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2000:CD001216. [PMID: 10796760]
30. Day LW, Bhuket T, Allison J. FIT testing: an overview. Curr Gastroenterol Rep. 2013;15:357. [PMID: 24218070]
31. Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med. 2012;55:87-92. [PMID: 22634386]
32. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210-4. [PMID: 16891354]
33. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62-8. [PMID: 19671542]
34. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82-90. [PMID: 18482589]
35. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171-81.
36. Collins JF, Lieberman DA, Durbin TE, et al; Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med. 2005;142:81-5. [PMID: 15657155]
37. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86-94. [PMID: 15657156]
38. Segnan N, Armaroli P, Bonelli L, et al; SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst. 2011;103:1310-22. [PMID: 21852264]
39. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sigmoi-doscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9:e1001352. [PMID: 23226108]
40. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-8. [PMID: 10900274]
41. Quintero E, Castells A, Bujanda L, et al; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697-706. [PMID: 22356323]
42. Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident latestage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158:312-20. [PMID: 23460054]
43. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22-30. [PMID: 21200035]
44. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81. [PMID: 8247072]
45. Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008;299:1027-35. [PMID: 18319413]
46. Minoo P, Zlobec I, Peterson M, et al. Characterization of rectal, proximal and distal colon cancers based on clinico-pathological, molecular and protein profiles. Int J Oncol. 2010;37:707-18. [PMID: 20664940]
47. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007;65:757-66. [PMID: 17466195]
48. Ko CW, Riffle S, Michaels L, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010;8:166-73. [PMID: 19850154]
49. Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc. 2007;65:648-56. [PMID: 17173914]
50. de Haan MC, van Gelder RE, Graser A, et al. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol. 2011;21:1747-63. [PMID: 21455818]
51. Zalis ME, Barish MA, Choi JR, et al; Working Group on Virtual Colonoscopy. CT colonography reporting and data system: a consensus proposal [Editorial]. Radiology. 2005;236:3-9. [PMID: 15987959]
52. Zalis ME, Blake MA, Cai W, et al. Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med. 2012;156:692-702. [PMID: 22586008]
53. Howard K, Salkeld G, Pignone M, et al. Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment. Value Health. 2011;14:1146-52. [PMID: 22152186]
54. Kim DH, Pickhardt PJ, Hanson ME, et al. CT colonography: performance and program outcome measures in an older screening population. Radiology. 2010;254:493-500. [PMID: 20093521]
55. Edwards JT, Wood CJ, Mendelson RM, et al. Extracolonic findings at virtual colonoscopy: implications for screening programs. Am J Gastroenterol. 2001;96:3009-12. [PMID: 11693340]
56. Lieberman D. Screening for colorectal cancer in individuals at average risk: current methods and emerging issues. JAMA Intern Med. 2014;174:10-1. [PMID: 24145734]
57. Skally M, Hanly P, Sharp L. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Health Econ Health Policy. 2013;11:181-92. [PMID: 23549792]
58. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2013;11:1313-8. [PMID: 23639600]
59. Imperiale TF, Ransohoff D F, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287-97.
60. Heigh RI, Yab TC, Taylor WR, et al. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT). PLoS One. 2014;9:e85659. [PMID: 24465639]
61. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-82. [PMID: 22493463]
62. Gupta S, Halm EA, Rockey DC, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173:1725-32. [PMID: 23921906]
63. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:96-104. [PMID: 12118964]
64. Lin OS, Kozarek RA, Schembre DB, et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA. 2006;295:2357-65. [PMID: 16720821]
65. Whitlock EP, Lin J, Liles E, et al Rockville, MD: Agency for Healthcare Research and Quality; 2008.
66. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-71. [PMID: 8942774]
67. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008;95:1029-36. [PMID: 18563785]
68. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674-80. [PMID: 15188160]